Miromatrix lands $15.7M for organ-growing tech

Miromatrix Medical Inc., a biotech company whose long-term goal is to grow human organs using a patient ’s own cells, has closed on a $15.7 million round of funding. Participating investors include a multibillion-dollar health care company that Miromatrix CEO Jeff Ross declined to name.  Eden Prairie-based Miromatrix plans to put the capital partly toward further development and testing of its te chnology, which was first developed by researchers at the University of Minnesota. The company strips…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news